ACRYSOF® Restor Apodized Diffractive IOL Postmarket Evaluation of Clinical Outcomes and Life-Style Visual Performance RESTOR IOL SN60WF IOL (Control Group)
Withdrawn before enrolling · Phase 4
Conditions studied: Refractive Assessment
In brief
The objective of the research on the Restore Intra Ocular Lens Implant (IOL) is to determine the clinical visual outcomes following bilateral implantation of the IOL compared to a control IOL and to demonstrate what percentage of the subjects obtain spectacle freedom.
Key facts
- Study ID
- NCT00345111
- Run by
- University of Texas Southwestern Medical Center
- People needed
- 0
- Starts
- 2005-07-01
- Expected to finish
- 2007-12-01
- Last updated by the study team
- 2018-08-16
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: accepted.
Where it is running
- University of Texas Southwestern Medical Center at Dallas — Dallas, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.